Cellebrite DI Ltd (NASDAQ:CLBT) currently has a daily average trading volume of 1.23M but it saw 1541093 shares traded in last market. With a market cap of 3.87B USD, the company’s current market price of $16.16 came falling about -0.68 while comparing to the previous closing price of $16.27. In past 52 weeks, the stock remained buoying in the range of price level as high as $26.30 and as low as $11.45.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Needham which reiterated the stock as “Buy” in its note to investors issued on March 28, 2024, recommending a price target of between $13 and $13.50 for it. BofA Securities issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $9 and $12.
Over the week, CLBT’s stock price is moving -3.00% down while it is -18.59% when we observe its performance for the past one month. Year-to-date it is -26.65% down and over the past year, the stock is showing an upside performance of 52.89%.
Currently, Cellebrite DI Ltd’s total number of outstanding shares is 239.47M. Company’s return on investment (ROI) stands at -52.51% and return on equity (ROE) at -115.35%. It has a 41.78 of forward P/E ratio. Stock’s beta reads 1.32. Stock has a price to book (P/B) ratio of 10.65 while price to sale or P/S ratio amounts to 9.23. Its return on asset (ROA) is -31.35% on average.
